Key result
Intracoronary infusion of endothelin-1 did not induce any change in regional or global myocardial function in swine, unlike dobutamine which increased segmental shortening.
Answers are grounded in this paper and cite their sources.
Questions direct myocardial effects of endothelin-1; leaves open its role in human coronary pathophysiology.
The vasoconstrictive peptide endothelin-1 (ET-1) has been reported to exert a very important positive inotropic effect in vitro. To assess the effect of ET-1 on myocardial contractility in vivo, we compared the effect of intracoronary infusion of 10(-8) M ET-1 (constant coronary blood flow) to that of 10(-8) M dobutamine in 8 swine. ET infusion did not produce changes in segmental shortening (control vs. drug, mean +/- SD): 33.8 +/- 14.3 vs. 30.8 +/- 12.1%, shortening velocity: 10.3 +/- 4.3 vs. 10.7 +/- 4.5 mm/s, or maximum +dP/dt: 1,691 +/- 701 vs. 1,772 +/- 773 mm Hg/s, whereas dobutamine infusion induced an important increase in these measurements; segmental shortening: 36.9 +/- 14 vs. 48.4 +/- 18.8%, shortening velocity: 10.1 +/- 2.6 vs. 14.7 +/- 4.5 mm/s, and maximum +dP/dt: 2,041 +/- 567 vs. 2,389 +/- 765 mm Hg/s (all p less than 0.05). Mean myocardial blood flow assessed by microspheres was unchanged by ET-1 despite a marked increase in coronary artery pressure (88.6 +/- 12.9 vs. 157 +/- 8.8 mm Hg, p less than 0.001). Regional infusion of ET-1 at a dose provoking extensive coronary vasoconstriction does not induce any change in regional or global myocardial function in swine.
No takes yet. Share an insight, caveat, or question.
Ricou et al. (1992) studied this question. Endothelin-1 (ET-1) vs. Dobutamine (10(-8) M) was evaluated on Segmental shortening. Intracoronary infusion of endothelin-1 did not induce any change in regional or global myocardial function in swine, unlike dobutamine which increased segmental shortening.
Synapse has enriched 10 related papers. Consider them for comparative context: